In the last years, an increased interest has been shown in considering the brain-derived neurotrophic factor (BDNF) as a promising biomarker of neurodegeneration, which may not only aid in the diagnosis of ALS, but might also predict clinical course and progression of the disease. Here, BDNF is linked to amyotrophic lateral sclerosis.